Skip to main content
24 August 2026
19 August 2024

Insulet Pharma Opens Manufacturing Facility in Malaysia

Insulet Corporation, the global leader in tubeless insulin pump technology with its Omnipod  brand of products, hosted a grand opening celebration at its new manufacturing facility in Johor Bahru, Malaysia. “Insulet’s remarkable growth is driven by our market-leading Omnipod 5, the first and only tubeless automated i…

08 August 2024

Parse Biosciences Partners with Taiwan-based Prisma Biotech to Extend Reach in Asia

Parse Biosciences, a leading provider of accessible and scalable single cell sequencing solutions, announced an agreement with Taipei-based Prisma Biotech to broaden Parse’s reach in Taiwan and across Asia-Pacific. “Biotech, pharma, and academic researchers across Asia are boosting demand for Parse’s Evercode single …

08 August 2024

Cipla EU to invest EUR 3 million in Ethris to develop mRNA-based therapies

Cipla Limited announced that its wholly-owned subsidiary in United Kingdom, Cipla (EU) Limited will invest an additional EUR 3 million in Ethris GmbH (“Ethris”), a global leader in delivering mRNAs directly to the respiratory system. This additional investment through a convertible loan will accelerate Cipla’s partici…

31 July 2024

Merck Invests € 62 Million in New Quality Control Facility in, Germany

Merck, a leading science and technology company, announces an investment of € 62 million at its Darmstadt headquarters in a new quality control building for its Life Science business. The facility will bring together approximately 135 employees across several departments into one collaborative state-of-the-art space. …

23 July 2024

Vividion Therapeutics to Expand with New Global Research and Development Center

Vividion Therapeutics, Inc, a clinical stage biopharmaceutical company utilizing novel discovery technologies to unlock high-value, traditionally undruggable targets with precision therapeutics for devastating cancers and immune disorders, announced it will expand its global innovation capabilities with a new research…

22 July 2024

Sanofi to Invest €400 Million in Expanding Hyderabad GCC, Aiming for 2600 Employees

Sanofi Healthcare India Pvt. Ltd. announces the expansion of its Global Capacity Centre (GCC) in Hyderabad, with plans to invest €400 million over the next six years, with €100 million by 2025. Over the next two years, this GCC (hub) will expand to host up to ~2600 employees, making it the largest of Sanofi’s four glo…

Page 33 of 58